Review class options below to expedite your booking experience! We DO NOT partner with third-party ticket vendors. If you experience any difficulty during the ticket purchasing process, we are unable to accommodate for this. We DO NOT partner with third party-ticket vendors. BioCareSD has reimagined specialty distribution, focusing on trust, transparency, and operational excellence. Headquartered in Frisco, Texas, AllyGPO partners with community-based specialty practices and pharmaceutical manufacturers across the U.S.<\/p>\n

As a new member, you\u2019ll partner with a dedicated CNECT representative who gets to know your organization inside out. As a result, its members have access to the products they need at prices they would not otherwise be offered. A group purchasing organization (GPO) is a company that leverages the purchasing power of its members to negotiate special pricing with suppliers.<\/p>\n

About AllyGPOAllyGPO\u00ae is a leading innovator and next-generation specialty group purchasing organization (GPO) equipping independent, community-based practices with advanced, technology-driven solutions and proprietary tools to navigate the complex specialty drug market. This gives customers operational savings, reliable data, and continuity, avoiding cash constraints, reporting inaccuracies, and multi\u2013year disruptions. Technology Built for Specialty PracticesCentral to the partnership's growth is AllyIQ, AllyGPO's AI-enabled intelligence center for optimizing drug management. "BioCareSD and AllyGPO, through consistent actions and collaboration, have demonstrated their genuine commitment to preserving retina practice independence in meaningful, practical ways. Choosing to partner with them enables RACI to better manage day-to-day operational and financial demands while securing long-term resilience with more efficient workflows and greater visibility from data-driven analytics." In retina, where drugs often represent the highest cost but also the highest return on investment for practice profitability, the partnership's value proposition has resonated equally. OCSRI, a physician-owned oncology network, realized significant operational gains since implementing AllyIQ, including a 35-day improvement in rebate payment timing, 99% performance visibility against estimated rebate opportunity, a 75% reduction in drug ordering time, a 10% reduction in inventory days on hand, and 99% drug audit accuracy.<\/p>\n

Proven Results Across Oncology and RetinaThe partnership's impact is demonstrated by measurable outcomes across its member practices. Together, they have introduced a new model that combines AllyGPO's AI-enabled practice intelligence platform, AllyIQ\u00ae, with BioCareSD's high-touch, service-driven specialty distribution. A New Model Built for Practice IndependenceAcross the healthcare landscape, large GPOs and specialty distributors have evolved into vertically integrated organizations that are acquiring physician practices and tightening control over both the supply chain and sites of care. In just three years, the partnership has expanded to serve a growing roster of community oncology and independent retina practices nationwide, more than tripling its retina footprint in 2025 alone.<\/p>\n